查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528976

阴茎植入物市场规模 - 按植入物类型（充气式、非充气式）、材料（硅胶、Bioflex）、最终用途（医院、门诊手术中心）和全球预测，2024 - 2032 年

Penile Implants Market Size - By Implant Type (Inflatable, Non-inflatable), Material (Silicone, Bioflex), End-use (Hospitals, Ambulatory Surgical Centres) & Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于全球勃起功能障碍 (ED) 盛行率不断上升，预计 2024 年至 2032 年间，阴茎假体市场规模的复合年增长率将达到 4.7%。据报道，预计到 2025 年，勃起功能障碍将影响全球 3.22 亿男性。 ED 负担日益加重可能是由多种因素造成的，包括老化、心血管疾病、糖尿病、高血压以及吸烟和饮酒等生活方式的选择。随着全球人口老化和这些健康状况的发病率不断增加，对有效 ED 治疗（包括阴茎植入物）的需求将相应增加。

新兴经济体不断增长的医疗基础设施以及不断增加的医疗支出正在推动市场扩张。消除 ED 污名化和促进有关性健康的公开讨论的转变正在鼓励更多男性寻求治疗。随着越来越多的人获得医疗保健服务，预计 ED 的诊断和治疗率将会上升，导致产品需求增加。

阴茎植入物产业按植入物类型、材料、最终用途和地区进行分类。

根据植入物类型，由于与充气植入物相比，非充气植入物简单、可靠且易于使用，预计到 2032 年，非充气植入物市场规模将大幅成长。非充气阴茎植入物提供简单的外科手术，机械故障的风险较低。这些植入物也为性活动提供持续的准备状态，同时消除了对复杂充气机制的需求。

由于这些设施提供的效率、便利性和成本效益，预计到 2032 年，门诊手术中心领域的阴茎植入物市场将录得较高的收入份额。门诊手术中心 (ASC) 提供专业的门诊手术护理，使患者能够在比传统医院更不那么令人生畏、对患者更友好的环境中接受阴茎植入手术。这些设定还可以缩短手术时间、减少住院时间并降低整体医疗费用。

在医疗保健意识不断提高、可支配收入增加以及导致勃起功能障碍的生活方式疾病日益流行的推动下，亚太地区阴茎植入物行业规模将在 2032 年大幅增长。不断扩大的中产阶级人口变得更加註重健康，并愿意投资先进的医疗手段。快速的城市化和生活方式的改变进一步导致糖尿病、高血压和其他与 ED 相关疾病的发病率升高，从而促进了区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 勃起功能障碍的发生率上升
      • 技术进步
      • 慢性病盛行率不断上升
    • 产业陷阱与挑战
      • 与手术相关的高成本
      • 存在替代药物治疗
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按植入物类型，2021 - 2032 年

  • 主要趋势
  • 充气的
  • 非充气式

第 6 章：市场估计与预测：按材料划分，2021 - 2032 年

  • 主要趋势
  • 硅酮
  • 百福莱克斯
  • 其他材料

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • Boston Scientific Corporation
  • Coloplast Corp
  • Dornier MedTech
  • Eska Medical Gmbh
  • Giant Medical LLC
  • GT Urological, LLC
  • Owen Mumford Ltd.
  • Pos-T-Vac, Inc.
  • Promedon
  • Reflexonic LLC
  • Rigicon Inc.
  • Silimed
  • Sofregen Medical Inc.
  • Uroplasty Inc.
  • Zephyr Surgical Implants
简介目录
Product Code: 9426

Penile implants market size is projected to witness a 4.7% CAGR between 2024 and 2032 driven by the rising prevalence of erectile dysfunction (ED) globally. As per reports, it is projected that by 2025, erectile dysfunction will affect 322 million men worldwide. This growing burden of ED can result from various factors including aging, cardiovascular diseases, diabetes, hypertension, and lifestyle choices, such as smoking and alcohol consumption. With the aging global population and the increasing incidence of these health conditions, the demand for effective ED treatments, including penile implants, will rise correspondingly.

The growing healthcare infrastructure in emerging economies, coupled with increasing healthcare expenditure are fueling the market expansion. The shift towards destigmatizing ED and promoting open discussions about sexual health is encouraging more men to seek treatment. As more individuals are gaining access to healthcare services, the diagnosis and treatment rates of ED are expected to rise, leading to higher product demand.

The penile implants industry is classified into implant type, material, end-use and region.

Based on implant type, the market size from the non-inflatable segment is projected to witness substantial growth through 2032 due to simplicity, reliability, and ease of use compared to inflatable implants. Non-inflatable penile implants offer a straightforward surgical procedure with a lower risk of mechanical failure. These implants also provide a constant state of readiness for sexual activity while eliminating the need for complex inflation mechanisms.

Penile implants market from the ambulatory surgical centers segment is predicted to record a high revenue share by 2032 owing to the efficiency, convenience, and cost-effectiveness offered by these facilities. Ambulatory surgical centers (ASCs) provide specialized, outpatient surgical care, allowing patients to undergo penile implant procedures in a less intimidating, more patient-friendly environment compared to traditional hospitals. These settings also offer results in shorter procedure times, reduced hospital stays, and lower overall healthcare costs.

Asia Pacific penile implants industry size will grow significantly through 2032 driven by rising healthcare awareness, increasing disposable incomes, and the growing prevalence of lifestyle diseases leading to erectile dysfunction. The expanding middle-class population is becoming more health-conscious and willing to invest in advanced medical treatments. Rapid urbanization, and changing lifestyles are further contributing to the higher incidences of diabetes, hypertension, and other conditions associated with ED, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of erectile dysfunction
      • 3.2.1.2 Technological advancement
      • 3.2.1.3 Growing prevalence of chronic diseases
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with the procedure
      • 3.2.2.2 Presence of alternative drug treatment
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Implant Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Inflatable
  • 5.3 Non-inflatable

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Silicone
  • 6.3 Bioflex
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centres
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Boston Scientific Corporation
  • 9.2 Coloplast Corp
  • 9.3 Dornier MedTech
  • 9.4 Eska Medical Gmbh
  • 9.5 Giant Medical LLC
  • 9.6 GT Urological, LLC
  • 9.7 Owen Mumford Ltd.
  • 9.8 Pos-T-Vac, Inc.
  • 9.9 Promedon
  • 9.10 Reflexonic LLC
  • 9.11 Rigicon Inc.
  • 9.12 Silimed
  • 9.13 Sofregen Medical Inc.
  • 9.14 Uroplasty Inc.
  • 9.15 Zephyr Surgical Implants